Company page

Altimmune, Inc.

Altimmune, Inc. is a publicly traded company listed under the ticker ALT, operating in the American market. With a market capitalization of approximately $525 million, Altimmune focuses on developing innovative therapeutics for various diseases. The company is committed to advancing its pipeline of products to address significant unmet medical needs.